Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04342364 · ClinicalTrials.gov registry record · NA

Oocyte Survival After Vitrification With Slush Nitrogen Compared With Liquid Nitrogen

A NA study of Infertility, sponsored by Reproductive Medicine Associates of New Jersey.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT04342364 is a NA study of Infertility that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 27 participants, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04342364, a NA study of Infertility, has completed, sponsored by Reproductive Medicine Associates of New Jersey.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if the use of slush nitrogen results in higher post-thaw survival rates for oocytes compared to conventionally used liquid nitrogen.

Conditions Studied

Interventions

  • OTHER Vitrification via slush nitrogen
  • OTHER Vitrification via liquid nitrogen

Study Locations (1)

New Jersey

  • Reproductive Medicine Associates of New Jersey - Basking Ridge

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2020-04-08
Est. Completion 2021-07-01
Phase NA

What the Registry Record Tells You About NCT04342364

The ClinicalTrials.gov registry entry for NCT04342364 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower). The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Vitrification via slush nitrogen is the first listed.

NCT04342364 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT04342364 about?

NCT04342364 is a clinical study titled "Oocyte Survival After Vitrification With Slush Nitrogen Compared With Liquid Nitrogen". The purpose of this study is to determine if the use of slush nitrogen results in higher post-thaw survival rates for oocytes compared to conventionally used liquid nitrogen.

What is the current status of trial NCT04342364?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2020-04-08. Estimated completion is 2021-07-01.

What conditions does trial NCT04342364 study?

This clinical trial studies the following conditions: Infertility.

What interventions are being tested in trial NCT04342364?

The interventions under investigation include: Vitrification via slush nitrogen (OTHER), Vitrification via liquid nitrogen (OTHER).

Who is sponsoring clinical trial NCT04342364?

This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04342364 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.